Lipoprotein Size and Atherosclerosis Susceptibility in <b> <i>Apoe</i> </b> <sup>−/−</sup> and <b> <i>Ldlr</i> </b> <sup>−/−</sup> Mice

  • Murielle M. Véniant
    From Amgen Inc (M.M.V.), Thousand Oaks, Calif; the Gladstone Institute of Cardiovascular Disease (S.W., S.G.Y.), University of California, San Francisco; the Cardiovascular Research Institute (S.G.Y.), University of California, San Francisco; and the Department of Medicine (S.G.Y.), University of California, San Francisco, and the Medical Service (S.G.Y.), San Francisco General Hospital, San Francisco, Calif.
  • Shannon Withycombe
    From Amgen Inc (M.M.V.), Thousand Oaks, Calif; the Gladstone Institute of Cardiovascular Disease (S.W., S.G.Y.), University of California, San Francisco; the Cardiovascular Research Institute (S.G.Y.), University of California, San Francisco; and the Department of Medicine (S.G.Y.), University of California, San Francisco, and the Medical Service (S.G.Y.), San Francisco General Hospital, San Francisco, Calif.
  • Stephen G. Young
    From Amgen Inc (M.M.V.), Thousand Oaks, Calif; the Gladstone Institute of Cardiovascular Disease (S.W., S.G.Y.), University of California, San Francisco; the Cardiovascular Research Institute (S.G.Y.), University of California, San Francisco; and the Department of Medicine (S.G.Y.), University of California, San Francisco, and the Medical Service (S.G.Y.), San Francisco General Hospital, San Francisco, Calif.

抄録

<jats:p> Two hypercholesterolemic mouse models, the apo-E–deficient mouse ( <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> ) and the LDL receptor–deficient mouse ( <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> ), have been used extensively as animal models of atherogenesis. Total plasma cholesterol levels in chow-fed <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> mice are much higher than in <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> mice. In a recent study, we managed to even-up the cholesterol levels in <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> mice and <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> mice by making both models homozygous for the <jats:italic>Apob</jats:italic> <jats:sup>100</jats:sup> (apo B-100–only) allele. On a chow diet, apo-E–deficient apo B-100–only mice ( <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> ) and LDL receptor–deficient apo B-100–only mice ( <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> ) had similar total plasma cholesterol levels (≈300 mg/dL). The plasma of <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> mice contained large numbers of small lipoproteins, whereas the plasma of <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> mice contained much lower levels of much larger lipoproteins. Interestingly, the <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> mice developed far more extensive atherosclerotic lesions than the <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> mice. The finding of substantially more atherosclerosis in <jats:italic>Ldlr</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> mice than in <jats:italic>Apoe</jats:italic> <jats:sup>−/−</jats:sup> <jats:italic>Apob</jats:italic> <jats:sup>100/100</jats:sup> mice, despite nearly identical cholesterol levels, suggests that large numbers of small apo B-100–containing lipoproteins are far more atherogenic than lower numbers of large apo B-100–containing lipoproteins. </jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ